Evidence-based·Updated November 19, 2026·How we grade evidence

Melanotan II

PeptideResearch peptide

In tiny 1990s studies, melanotan II darkened the skin of 2 of 3 men and caused erections in 17 of 20 men with erectile dysfunction, with frequent nausea. It was never approved. Case reports describe melanoma, rapidly changing moles, priapism, muscle breakdown with kidney injury, kidney infarction and a brain swelling syndrome in people using products bought online. It is not the same as the approved drugs afamelanotide (Scenesse) or bremelanotide (Vyleesi).

Taking Melanotan II with other supplements or medications?Check your whole list for interactions. Free, no account.

Research compound: not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.

Quick decision guide

May help most

No approved use; research participants in registered trials only

Common dosing range

No approved or established dose. 1990s trials used 0.025 mg per kg injected under the skin under supervision

When to expect effects

Erections began within hours of an injection in trials; skin darkening was measured a week after 5 doses

Watch out for

Not FDA-approved; FDA cites case reports of melanoma, PRES, sympathomimetic toxidrome and priapism; case reports describe darkened and new moles, which can make skin cancer harder to spot; online products are unverified

What is it

Melanotan II (MT-II) is a lab-made peptide that copies alpha-melanocyte stimulating hormone (alpha-MSH), the body's own signal for skin pigment. It was tested in a few small studies in the 1990s and then never developed into an approved drug, but it is sold online as injections and nasal sprays for tanning and sexual arousal. It is not FDA-approved for any use. It is often confused with two different, approved medicines that act on the same family of receptors: afamelanotide (Scenesse) is an implant placed under the skin by a health professional, approved to increase pain-free light exposure in adults with a history of phototoxic reactions from erythropoietic protoporphyria, a rare light-sensitivity disease; bremelanotide (Vyleesi) is an injection approved for acquired, generalized low sexual desire (HSDD) in premenopausal women. Melanotan II is neither of them. FDA's compounding safety page lists melanotan II among bulk substances previously in category 2 (substances that may present significant safety risks) whose nominations were withdrawn by the nominators, and says published case reports discuss serious adverse events including melanoma, a brain swelling syndrome (PRES), sympathomimetic toxidrome and priapism. Separately, an FDA early announcement says its Pharmacy Compounding Advisory Committee will discuss melanotan II, among bulk substances being considered for inclusion on the 503A bulks list, at a meeting FDA will host before the end of February 2027 (date not yet set). A phase 2 trial of melanotan II with light therapy for vitiligo is registered and recruiting.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You qualify for a registered clinical trial of melanotan II (for example the phase 2 vitiligo trial listed on ClinicalTrials.gov) and want to take part under medical supervision
You have erythropoietic protoporphyria, low sexual desire or erectile dysfunction and want to ask a doctor about approved treatments, such as afamelanotide or bremelanotide where they fit

Probably skip if…

You want a tan: case reports describe darkened and new moles and melanoma in users, and no study shows it protects against the sun
You would be buying injections or nasal sprays online: they are unapproved and their content is unverified
You have many moles, a history of melanoma, or a family history of skin cancer
You want it for erections or libido: it was never approved for this, nausea was frequent in trials (severe in 12.9% of men at the trial dose), and priapism has been reported

Evidence at a glance

erections in men with erectile dysfunction

Limited Evidence
Effect
17 of 20 men had erections; about 38 to 45 minutes of strong rigidity versus 2 to 3 minutes on placebo
Best fit
Research participants only
Time
Within the 6-hour monitoring period after an injection

skin darkening (tanning)

Mixed Evidence
Effect
Measurable darkening in 2 of 3 men
Best fit
Research participants only
Time
Seen one week after 5 doses

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

erections in men with erectile dysfunction

Disease adjunct
Limited Evidence

Two small double-blind, placebo-controlled crossover trials from one US group tested 0.025 mg per kg injected under the skin. In 10 men with psychogenic erectile dysfunction, 8 developed erections; the time with tip rigidity above 80% averaged 38.0 minutes versus 3.0 on placebo (p = 0.0045). In 10 men with organic risk factors, erections followed 12 of 19 injections versus 1 of 21 placebo doses (45.3 versus 1.9 minutes of rigidity, P = 0.047), and sexual desire scores were higher. Across both, 17 of 20 men had erections, but nausea and yawning were frequent: the authors reported severe nausea in 12.9% at this dose, and after 4 of 19 injections in the organic group. The trials tested at most two doses per man, and the drug was never developed further for this use.

Effect size
17 of 20 men had erections; about 38 to 45 minutes of strong rigidity versus 2 to 3 minutes on placebo
Time to effect
Within the 6-hour monitoring period after an injection
Best fit
Research participants only
Less likely
Anyone seeking treatment now: approved erectile dysfunction medicines exist, and these trials tested only one or two doses

Bottom line: It caused erections in tiny 1990s trials, with frequent nausea, and was never approved.

skin darkening (tanning)

Biomarker support
Mixed Evidence

In a single-blind, placebo-controlled pilot phase 1 study of 3 healthy men, injections under the skin on alternate weekdays for 2 weeks (5 doses, 0.01 to 0.03 mg per kg) increased pigmentation of the face, upper body and buttocks in 2 men, measured by reflectance one week after the last dose. Nausea was reported at most doses, and erections occurred for 1 to 5 hours after dosing. No study has tested whether this tan protects against sunburn or skin cancer, and case reports describe new and darkened moles and melanoma in users.

Effect size
Measurable darkening in 2 of 3 men
Time to effect
Seen one week after 5 doses
Best fit
Research participants only
Less likely
People with many moles or a personal or family history of melanoma, for whom it may be dangerous

Bottom line: It can darken skin, but no study shows the tan is protective, and mole changes and melanoma have been reported.

How it works

Melanotan II is a ring-shaped (cyclic) seven-amino-acid version of alpha-MSH that its developers described as superpotent. It switches on several melanocortin receptors without selectivity. In skin, this increases pigment, so the skin darkens. In the brain, the same signal causes spontaneous erections, nausea, yawning and stretching, and reduced appetite, which is why it was studied for erectile dysfunction. Because it stimulates pigment cells throughout the skin, case reports describe darkening of existing moles and new moles appearing, a key reason dermatologists have reported concerns.

How to take it

1. Typical dose
There is no approved or established dose. In the 1990s studies, men received 0.01 to 0.03 mg per kg injected under the skin, and the erectile dysfunction trials used 0.025 mg per kg under supervision. These are studied doses, not recommendations.
2. Higher studied dose
At 0.03 mg per kg, one of two men in the first study had moderate (grade II) sleepiness and fatigue. In a published case report, a man who injected 6 mg bought online developed a racing heart and severe muscle breakdown.
3. Timing
Trials gave single injections or injections every other day for 2 weeks.
4. With food
Not established.
5. Split dosing
Not established.
6. How long to try
Human studies lasted 2 weeks or less. There are no long-term data.

What to track

Any new mole, or a mole that darkens, grows, changes shape or bleeds: see a dermatologist promptly
An erection lasting more than 4 hours: this is an emergency
Severe headache, confusion, vision changes or seizures: get emergency care
Muscle pain, dark urine, racing heart or severe sweating: get emergency care
Nausea, flushing, yawning and loss of appetite, the most common effects in trials

Bottom line: No approved dose exists; the products sold online are unverified and have been linked to serious harm.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, reported as severe in 12.9% at 0.025 mg per kg in the erectile dysfunction trials (after 4 of 19 injections in one of them)Yawning and stretchingReduced appetiteSpontaneous erections lasting 1 to 5 hoursSleepiness and fatigue at higher dosesDarkening of the skin, and, in case reports, darkening of existing moles and new moles

Serious risks

Who should avoid it

Pregnancy & breastfeeding

There are no human data on melanotan II in pregnancy or breastfeeding: the published trials enrolled men only. Ask your doctor before any use if you are pregnant, breastfeeding or planning a pregnancy.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

There is no FDA-approved melanotan II product, so no label can show FDA approval
Approved medicines in this family carry a DailyMed label: Scenesse (afamelanotide implant, inserted by a health professional) and Vyleesi (bremelanotide injection); neither is melanotan II
The legitimate way to receive melanotan II today is a registered clinical trial listed on ClinicalTrials.gov

Be skeptical of…

"Safe tan without the sun" or "protects against sunburn or skin cancer": no study shows protection, and melanoma has been reported in users
"Same as Scenesse" or "same as Vyleesi": these are different, approved drugs with specific uses; melanotan II is neither
"FDA-approved" or "clinic-grade" melanotan II: no product is approved
"Nasal spray is safer": a mouth melanoma was reported after nasal spray use, and sprays are just as unverified
"For research use only" vials sold to consumers: unapproved and unverified
"Libido booster" or "natural Viagra": only one or two doses were ever tested in men with erectile dysfunction, with frequent severe nausea

Frequently asked questions

Is melanotan II FDA-approved?⌄

No. Melanotan II is not approved for any use in the US. FDA's compounding safety page lists it among bulk substances previously in category 2 (substances that may present significant safety risks) whose nominations were withdrawn by the nominators. Separately, an FDA early announcement says its Pharmacy Compounding Advisory Committee will discuss melanotan II, among substances being considered for the 503A bulks list, at a meeting before the end of February 2027. A phase 2 vitiligo trial is registered and recruiting.

Is melanotan II the same as Scenesse or Vyleesi?⌄

No. Afamelanotide (Scenesse) is an FDA-approved implant that increases pain-free light exposure in adults with a history of phototoxic reactions from erythropoietic protoporphyria. Bremelanotide (Vyleesi) is an FDA-approved injection for acquired, generalized low sexual desire in premenopausal women. Both act on melanocortin receptors, like melanotan II, but they are different molecules with their own trials, labels and safety monitoring. Melanotan II is neither.

Does melanotan II cause skin cancer?⌄

It has not been proven to cause it, but melanoma has been reported in several users, and one case report described new and darkened moles 24 hours after a single injection. Darker moles can make changes harder to spot. FDA's safety summary lists melanoma among serious adverse events in case reports. If you have used it, have your skin checked by a dermatologist.

Is a melanotan nasal spray safer than injections?⌄

There is no evidence that it is. Nasal sprays are equally unapproved and unverified, and a 2025 case report described a melanoma inside the mouth of a young woman who used a melanotan II nasal spray for tanning.

Can I use melanotan II with my supplements or medicines?⌄

No interaction studies with supplements or medicines exist, so nothing is known about combining it with them. Ask a doctor or pharmacist to review your full list.

What should I do if I have used it and feel unwell?⌄

Get emergency care for an erection lasting more than 4 hours, a severe headache, confusion, vision changes, seizures, chest pain, a racing heart, severe muscle pain or dark urine. Tell the doctors what you injected or sprayed and bring the product if you can.

References by claim

erections in men with erectile dysfunction

Wessells et al., 1998 · PubMed (1998) link

Wessells et al., 2000 · PubMed (2000) link

Wessells et al., 2000 · PubMed (2000) link

skin darkening (tanning)

Dorr et al., 1996 · PubMed (1996) link

Safety

Hjuler et al., 2014 · PubMed (2014) link

Ong et al., 2012 · PubMed (2012) link

Yassin Alsabbagh et al., 2025 · PubMed (2025) link

Schulze et al., 2014 · PubMed (2014) link

FDA: Certain bulk drug substances for use in compounding that may present significant safety risks · FDA link

Nelson et al., 2012 · PubMed (2012) link

Peters et al., 2020 · PMC (2020) link

Dreyer et al., 2019 · PMC (2019) link

Kaski et al., 2013 · PubMed (2013) link

FDA: Early announcement, meeting of the Pharmacy Compounding Advisory Committee (before the end of February 2027) · FDA link

Track Melanotan II with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 19, 2026·Evidence current as of Nov 19, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.